- £27.54bn
- £28.72bn
- £4.78bn
- 66
- 47
- 97
- 83
Annual income statement for 3i, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,136 | 342 | 1,980 | 4,194 | 4,777 |
| Cost of Revenue | |||||
| Gross Profit | 1,136 | 319 | 1,974 | 4,148 | 4,739 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | -94 | 127 | 125 | 176 | 202 |
| Operating Profit | 1,230 | 215 | 1,855 | 4,018 | 4,575 |
| Net Income Before Taxes | 1,230 | 215 | 1,855 | 4,018 | 4,575 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,242 | 214 | 1,855 | 4,013 | 4,573 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,242 | 214 | 1,855 | 4,013 | 4,573 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 1,242 | 214 | 1,855 | 4,013 | 4,573 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.28 | 0.223 | 1.92 | 4.14 | 4.74 |
| Dividends per Share |